Abstract
In their recent Immunology Today article
entitled 'Commercial vision needed in
the lab and dogged finance outside it',
A. A. van Es and J. J. Haaijman state
that governmental funding in the
Netherlands is being slowly but steadily
reduced and that scientists will have to
find alternative sources of funding.